Literature DB >> 31757226

Reduction in SNAP-23 Alters Microfilament Organization in Myofibrobastic Hepatic Stellate Cells.

Haleigh B Eubanks1, Elise G Lavoie1, Jessica Goree1, Jeffrey A Kamykowski2, Neriman Gokden3, Michel Fausther1, Jonathan A Dranoff1.   

Abstract

Hepatic stellate cells (HSC) are critical effector cells of liver fibrosis. In the injured liver, HSC differentiate into a myofibrobastic phenotype. A critical feature distinguishing myofibroblastic from quiescent HSC is cytoskeletal reorganization. Soluble NSF attachment receptor (SNARE) proteins are important in trafficking of newly synthesized proteins to the plasma membrane for release into the extracellular environment. The goals of this project were to determine the expression of specific SNARE proteins in myofibroblastic HSC and to test whether their alteration changed the HSC phenotype in vitro and progression of liver fibrosis in vivo. We found that HSC lack the t-SNARE protein, SNAP-25, but express a homologous protein, SNAP-23. Downregulation of SNAP-23 in HSC induced reduction in polymerization and disorganization of the actin cytoskeleton associated with loss of cell movement. In contrast, reduction in SNAP-23 in mice by monogenic deletion delayed but did not prevent progression of liver fibrosis to cirrhosis. Taken together, these findings suggest that SNAP-23 is an important regular of actin dynamics in myofibroblastic HSC, but that the role of SNAP-23 in the progression of liver fibrosis in vivo is unclear.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31757226      PMCID: PMC7284106          DOI: 10.3727/105221619X15742818049365

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  35 in total

1.  SNAP-23 and SNAP-25 are palmitoylated in vivo.

Authors:  K Vogel; P A Roche
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

Review 2.  Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.

Authors:  Natalie J Torok; Jonathan A Dranoff; Detlef Schuppan; Scott L Friedman
Journal:  Hepatology       Date:  2015-03-10       Impact factor: 17.425

Review 3.  The hepatic stellate (Ito) cell: its role in human liver disease.

Authors:  M L Hautekeete; A Geerts
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

4.  Immortal activated human hepatic stellate cells generated by ectopic telomerase expression.

Authors:  Bernd Schnabl; Youkyung Hwang Choi; John C Olsen; Curt H Hagedorn; David A Brenner
Journal:  Lab Invest       Date:  2002-03       Impact factor: 5.662

Review 5.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

6.  A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking.

Authors:  Young Ho Suh; Akira Terashima; Ronald S Petralia; Robert J Wenthold; John T R Isaac; Katherine W Roche; Paul A Roche
Journal:  Nat Neurosci       Date:  2010-01-31       Impact factor: 24.884

7.  Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition.

Authors:  Muhammad A Sohail; Ardeshir Z Hashmi; Wyel Hakim; Azuma Watanabe; Alexander Zipprich; Roberto J Groszmann; Jonathan A Dranoff; Natalie J Torok; Wajahat Z Mehal
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 8.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 9.  Cre-ativity in the liver: transgenic approaches to targeting hepatic nonparenchymal cells.

Authors:  Stephen N Greenhalgh; Kylie P Conroy; Neil C Henderson
Journal:  Hepatology       Date:  2015-04-13       Impact factor: 17.425

10.  F‑actin cytoskeleton reorganization is associated with hepatic stellate cell activation.

Authors:  Xiaodong Cui; Xiaoyun Zhang; Qingling Yin; Aixia Meng; Shaojuan Su; Xu Jing; Hong Li; Xiumei Guan; Xin Li; Shunmei Liu; Min Cheng
Journal:  Mol Med Rep       Date:  2014-03-11       Impact factor: 2.952

View more
  1 in total

Review 1.  Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain-Narrative Review.

Authors:  Magdalena Kocot-Kępska; Renata Zajączkowska; Joanna Mika; David J Kopsky; Jerzy Wordliczek; Jan Dobrogowski; Anna Przeklasa-Muszyńska
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.